Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
89.63 -6.96 / -7.21%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
89.24 -0.39 / -0.44%
 
Volume: 22.5K

Today’s Trading

Previous close96.59
Today’s open93.01
Day’s range87.63 - 94.30
Volume5,315,669
Average volume (3 months)13,181,407
Market cap$33.0B
Dividend yield--
Data as of 4:01pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+23.07%
Earnings growth (next 5 years)+15.49%
Revenue growth (last year)+43.22%
P/E ratio37.1
Price/Sales5.93
Price/Book6.08

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-3.13-2.20%
SHPGShire-6.92-4.40%
MYLMylan NV-0.94-1.83%
VRTXVertex Pharmaceutica...-4.61-5.32%
Data as of 3:59pm ET, 02/08/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)$2.60
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Howard Bradley Schiller
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Qubec

Forecasts

Partner Offers